- Home
- RSVR vs ZVRA Comparison
RSVR vs ZVRA Comparison
Compare RSVR & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSVR
- ZVRA
- Stock Information
- Founded
- RSVR 2007
- ZVRA 2006
- Country
- RSVR United States
- ZVRA United States
- Employees
- RSVR N/A
- ZVRA N/A
- Industry
- RSVR Movies/Entertainment
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- RSVR Consumer Discretionary
- ZVRA Health Care
- Exchange
- RSVR Nasdaq
- ZVRA Nasdaq
- Market Cap
- RSVR 528.3M
- ZVRA 433.5M
- IPO Year
- RSVR N/A
- ZVRA 2015
- Fundamental
- Price
- RSVR $7.25
- ZVRA $7.85
- Analyst Decision
- RSVR Strong Buy
- ZVRA Strong Buy
- Analyst Count
- RSVR 1
- ZVRA 8
- Target Price
- RSVR $12.50
- ZVRA $22.29
- AVG Volume (30 Days)
- RSVR 43.3K
- ZVRA 513.4K
- Earning Date
- RSVR 02-05-2025
- ZVRA 03-11-2025
- Dividend Yield
- RSVR N/A
- ZVRA N/A
- EPS Growth
- RSVR 4113.60
- ZVRA N/A
- EPS
- RSVR 0.12
- ZVRA N/A
- Revenue
- RSVR $156,433,584.00
- ZVRA $23,612,000.00
- Revenue This Year
- RSVR $10.97
- ZVRA $281.10
- Revenue Next Year
- RSVR $6.81
- ZVRA $97.98
- P/E Ratio
- RSVR $62.51
- ZVRA N/A
- Revenue Growth
- RSVR 11.32
- ZVRA N/A
- 52 Week Low
- RSVR $6.83
- ZVRA $4.20
- 52 Week High
- RSVR $9.83
- ZVRA $9.76
- Technical
- Relative Strength Index (RSI)
- RSVR 38.56
- ZVRA 47.41
- Support Level
- RSVR $7.05
- ZVRA $7.78
- Resistance Level
- RSVR $7.52
- ZVRA $8.33
- Average True Range (ATR)
- RSVR 0.28
- ZVRA 0.40
- MACD
- RSVR 0.01
- ZVRA -0.01
- Stochastic Oscillator
- RSVR 26.67
- ZVRA 45.30
About RSVR Reservoir Media Inc.
Reservoir Media Inc is an independent music company. The company's segment includes Music Publishing; Recorded Music and others. It generates the maximum of its revenue from the Music Publishing segment.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.